A detailed history of Elco Management Co., LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Elco Management Co., LLC holds 10,055 shares of FOLD stock, worth $95,321. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,055
Previous 11,405 11.84%
Holding current value
$95,321
Previous $65,000 21.54%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$5.84 - $8.57 $7,884 - $11,569
-1,350 Reduced 11.84%
10,055 $79,000
Q2 2025

Aug 04, 2025

SELL
$5.64 - $8.0 $56,546 - $80,208
-10,026 Reduced 46.78%
11,405 $65,000
Q1 2025

May 01, 2025

BUY
$8.16 - $9.85 $174,876 - $211,095
21,431 New
21,431 $174,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Elco Management Co., LLC Portfolio

Follow Elco Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elco Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elco Management Co., LLC with notifications on news.